BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 7892601)

  • 1. Tyrosine kinase inhibition: an approach to drug development.
    Levitzki A; Gazit A
    Science; 1995 Mar; 267(5205):1782-8. PubMed ID: 7892601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of tyrosine kinases in the treatment of psoriasis.
    Ben-Bassat H; Klein BY
    Curr Pharm Des; 2000 Jun; 6(9):933-42. PubMed ID: 10828317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of protein-tyrosine kinases by tyrphostins.
    Levitzki A; Gazit A; Osherov N; Posner I; Gilon C
    Methods Enzymol; 1991; 201():347-61. PubMed ID: 1658552
    [No Abstract]   [Full Text] [Related]  

  • 4. Protein tyrosine kinase inhibitors inhibit both proliferation and chemotaxis of vascular smooth muscle cells.
    Shimokado K; Yokota T; Kosaka C; Zen K; Sasaguri T; Masuda J; Ogata J
    Ann N Y Acad Sci; 1995 Jan; 748():171-5; discussion 175-6. PubMed ID: 7695163
    [No Abstract]   [Full Text] [Related]  

  • 5. Tyrphostins: tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction.
    Levitzki A
    FASEB J; 1992 Nov; 6(14):3275-82. PubMed ID: 1426765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors.
    Gillespie J; Dye JF; Schachter M; Guillou PJ
    Br J Cancer; 1993 Dec; 68(6):1122-6. PubMed ID: 8260363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissection of T cell antigen receptor signaling using protein tyrosine kinase inhibitors.
    Baldari CT; Telford JL
    Eur J Immunol; 1994 May; 24(5):1046-52. PubMed ID: 8181516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of calcineurin by the tyrphostin class of tyrosine kinase inhibitors.
    Martin BL
    Biochem Pharmacol; 1998 Aug; 56(4):483-8. PubMed ID: 9763224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibition of EGF-dependent proliferation of keratinocytes by tyrphostin tyrosine kinase blockers.
    Dvir A; Milner Y; Chomsky O; Gilon C; Gazit A; Levitzki A
    J Cell Biol; 1991 May; 113(4):857-65. PubMed ID: 1709168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activity of tyrosine kinase inhibitors: novel agents for psoriasis therapy.
    Ben-Bassat H
    Curr Opin Investig Drugs; 2001 Nov; 2(11):1539-45. PubMed ID: 11763154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The degree of inhibition of protein tyrosine kinase activity by tyrphostin 23 and 25 is related to their instability.
    Ramdas L; McMurray JS; Budde RJ
    Cancer Res; 1994 Feb; 54(4):867-9. PubMed ID: 7508821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells.
    Bilder GE; Krawiec JA; McVety K; Gazit A; Gilon C; Lyall R; Zilberstein A; Levitzki A; Perrone MH; Schreiber AB
    Am J Physiol; 1991 Apr; 260(4 Pt 1):C721-30. PubMed ID: 1850195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of phospholipase D of human platelets by protein tyrosine kinase inhibitors.
    Martinson EA; Scheible S; Presek P
    Cell Mol Biol (Noisy-le-grand); 1994 Jul; 40(5):627-34. PubMed ID: 7526916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrphostin attenuates platelet-derived growth factor-induced contraction in aortic smooth muscle through inhibition of protein tyrosine kinase(s).
    Sauro MD; Thomas B
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1119-25. PubMed ID: 8263773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Moloney murine leukemia virus replication by tyrphostins, tyrosine kinase inhibitors.
    Esther A; Iftach S; Esther P
    FEBS Lett; 1994 Mar; 341(1):99-103. PubMed ID: 8137930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tyrphostin on cell growth and tyrosine kinase activity of epidermal growth factor receptor in human gliomas.
    Miyaji K; Tani E; Shindo H; Nakano A; Tokunaga T
    J Neurosurg; 1994 Sep; 81(3):411-9. PubMed ID: 8057149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of tyrosine phosphorylation induce apoptosis in human leukemic cell lines.
    Bergamaschi G; Rosti V; Danova M; Ponchio L; Lucotti C; Cazzola M
    Leukemia; 1993 Dec; 7(12):2012-8. PubMed ID: 8255101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tyrosine phosphorylation potentiates substrate-induced neurite growth.
    Bixby JL; Jhabvala P
    J Neurobiol; 1992 Jul; 23(5):468-80. PubMed ID: 1279111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrphostin-induced differentiation of mouse erythroleukemia cells.
    Anafi M; Gazit A; Gilon C; Neriah YB; Levitzki A
    FEBS Lett; 1993 Sep; 330(3):260-4. PubMed ID: 8375496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells.
    Tallett A; Chilvers ER; Hannah S; Dransfield I; Lawson MF; Haslett C; Sethi T
    Cancer Res; 1996 Sep; 56(18):4255-63. PubMed ID: 8797601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.